Synovus Financial Corp Organon & Co. Transaction History

Synovus Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$19.27 - $24.63 $3.17 Million - $4.05 Million	-164,299 Reduced 94.26%	10,001 $208,000
Q1 2023 May 11, 2023	BUY	$21.42 - $32.08 $45,945 - $68,811	2,145 Added 1.25%	174,300 $4.1 Million
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $104,405 - $128,144	-4,479 Reduced 2.54%	172,155 $4.81 Million
Q3 2022 Oct 27, 2022	BUY	$23.4 - $34.25 $817,151 - $1.2 Million	34,921 Added 24.64%	176,634 $4.12 Million
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $18,331 - $22,523	579 Added 0.41%	141,713 $4.78 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $853,878 - $1.1 Million	28,042 Added 24.8%	141,134 $4.93 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $2.65 Million - $3.43 Million	92,328 Added 444.65%	113,092 $3.44 Million
Q3 2021 Nov 08, 2021	SELL	$28.63 - $35.64 $274,103 - $341,217	-9,574 Reduced 31.56%	20,764 $661,000
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $863,116 - $1.15 Million	30,338 New	30,338 $877,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.